Oncotherapeutic Application of Resveratrol-based Inorganic Nanoparticles.

Angela Perris, Sanchari Bhattacharya, Junaid Jibran Jawed, Muddasarul Hoda

Journal: Pharmaceutical nanotechnology 2022;9(4):271-280

PMID: 34488608

Abstract

BACKGROUND

Potential therapeutic benefits of natural phytoconstituents and the emergence of nano-structured drug delivery systems have expanded the scope of enhanced chemotherapy with minimal adverse effects. Various in vivo and in vitro studies have revealed Resveratrol to be a potent anti-carcinogenic agent. Researchers are currently applying the concept of nano-science for enhancing the delivery of phyto-drugs like resveratrol, in order to carry the drug to the affected tissues and organs of cancer patients with much ease and efficiency.

METHODS

The current review emphasizes the use of inorganic nanoparticles for enhancing the delivery and efficacy of resveratrol into otherwise inaccessible tumorigenic tissues.

CONCLUSION

The present review work summarizes a comprehensive update on the mechanism of actions of the resveratrol-based inorganic nanocomposite particles that are currently being studied against various cancer models. This work may be significant in laying the foundation for the future of metallic nanoparticles-based delivery and efficacy of phytochemicals in general and resveratrol in specific against non-invasive metastatic cancer.

Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Address: Department of Microbiology, St. Xavier\'s College, 30 Mother Teresa Sarani Kolkata 700016, West Bengal, India.; Guru Nanak Institute of Pharmaceutical Sciences and Technology, 157/F Nilgunj Road, Panihati, Kolkata-700114, India.; School of Biotechnology, Presidency University 2<sup>nd</sup> Campus, Kolkata- 700156, India.; Department of Biological Sciences, Aliah University, Kolkata-700160, India.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.